Editorial Stocks to Benefit from Potential Covid-19 Vaccines The Covid-19 pandemic has caused a deep impact on people’s livelihoods and health. The economic and social disruption caused by this unprecedented pandemic is devastating. As of November 24, official data from John Hopkins University shows that there are more than 59 million confirmed cases of Covid-19 worldwide. The only factor which keeps our spirits […] Written by marketfeed Team November 27, 2020April 21, 2022
Editorial The Atmanirbhar Bharat Abhiyan 3.0 Explained The Finance Ministry on Thursday (November 12) made a series of announcements with respect to a new stimulus package. Named as the Atmanirbhar Bharat Abhiyan 3.0, the package has allocated significant amounts to vital sectors of our economy. The total package has been estimated at Rs 2.65 lakh crore. With a focus on boosting production […] Written by Cherian Varghese November 12, 2020August 31, 2022
Editorial The Pfizer Vaccine – All You Need to Know A major announcement from the United States on November 9 has completely lifted our hopes and spirits! Since March, scientists around the world have been working tirelessly towards creating an effective vaccine against the novel coronavirus. And now, drugmakers Pfizer and BioNTech have come out with a very positive result. The vaccine developed by the […] Written by Cherian Varghese November 12, 2020August 31, 2022
Editorial 5 Reasons Why Nifty is Rising! Nifty 50 hit a record high on November 9 as the index closed at 12,461.05, up by 1.61%. The next day, Nifty jumped again with spring and concluded at 12,631. There has been a remarkable rally in the past few days which has taken Nifty 50 to even cross its pre-covid highs. Today, as of […] Written by marketfeed Team November 11, 2020April 21, 2022
Market News Top 10 News Pfizer’s Covid-19 Vaccine 90% Effective in Phase 3 – Top Indian Market News Covid-19 vaccine 90% effective in Phase-3 trial: Pfizer Pfizer, the US-based pharmaceutical firm, has stated that its vaccine was 90% effective in preventing Covid-19 infections in ongoing Phase-3 trials. The vaccine candidate is jointly developed by Pfizer and BioNTech. Pfizer has also stated that it expects to supply up to 50 million vaccine doses globally […] Written by marketfeed Team November 9, 2020April 21, 2022
Market News Top 10 News Finance Ministry Issues Guidelines to Implement Interest Waiver – Top Indian Market News Finance Ministry issues guidelines to implement interest waiver on loans Last week, the Supreme Court had asked Central Government to issue guidelines on implementing the waiver of interest on interest. Today, The Finance Ministry has issued operational guidelines on how to implement the interest waiver scheme on loans up to Rs 2 crore. The scheme […] Written by marketfeed Team October 24, 2020April 21, 2022
Daily Market Feed COVID-19 Vaccine unveiled – Share Market Today Nifty had a gap-up opening today, starting the day at 11,325 and touching a day-high of 11,372 soon after. However, the index corrected over the day, and closed at 11,324, up 0.58%. Nifty struggled to close above 11,350, and is yet to give a technically strong buy signal for the week. But keeping aside technical […] Written by marketfeed Team August 11, 2020April 21, 2022
Daily Market Feed Oxford University COVID 19 Vaccine Hopes – Share Market Today News Shots The first set of results from early-stage clinical trials of Oxford University Covid 19 vaccine has shown that the vaccine is safe and induces an immune reaction. Indian vaccine manufacturer Serum Institute, which has a manufacturing agreement with British pharma giant AstraZeneca, announced that it would seek regulatory approvals to manufacture the vaccine […] Written by marketfeed Team July 21, 2020April 21, 2022
Daily Market Feed COVID 19 Vaccine Expectations Strengthen – Share Market Today News Shots There are official statements from Russia which says they will make the COVID 19 vaccine available to the public next month. Zydus Cadila’s Chairman Pankaj Patel announced that they aim to complete late-stage trials for its coronavirus vaccine candidate ‘ZyCov-D’ by March 2021. Cadila will start production of 100 million doses of potential […] Written by marketfeed Team July 20, 2020April 21, 2022
